Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05618912 · ClinicalTrials.gov registry record · NA
Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 146
- Enrollment target
NCT05618912: Completed NA study, sponsored by Indiana University.
NCT05618912 is a NA study that has completed, run by Indiana University. The registered enrollment target is 146 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05618912, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 146 participants
- Enrollment target
Study Summary
Patients will be randomized either to receive standard daily dressing or hydrocolloid dressing using a randomization generator. After closing the wound with the sutures,the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days(Experimental) or the standard dressing (Control) that will be covered with petrolatum jelly and bandaging during this time period, which has to be re-applied daily. Patients and dermatologic surgeons will then complete surveys 7 days, 30 days, and 90 days after surgery to evaluate the cosmetic appearance of these scars.
Primary Outcome
Patient and surgeon assessment of cosmetic outcome using modified visual analogue scar scale. The minimum value is 1 and the maximum value is 10. 1 is the worst possible scar appearance and 10, is the best possible scar appearance.
Interventions
- DEVICE Hydrocolloid dressing
- OTHER Petrolatum jelly dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2022-10-17 |
| Est. Completion | 2023-10-16 |
| Phase | NA |
What the finished NCT05618912 record still lists
NCT05618912 is an interventional study that assigns participants to a tested intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 2 interventions - of which Hydrocolloid dressing is the first listed.
NCT05618912 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05618912 about?
NCT05618912 is a clinical study titled "Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment". Patients will be randomized either to receive standard daily dressing or hydrocolloid dressing using a randomization generator. After closing the wound with the sutures,the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days(Experimental) or the standard dressing ...
What is the current status of trial NCT05618912?
This trial is currently completed. It is a NA study. The enrollment target is 146 participants. The study started on 2022-10-17. Estimated completion is 2023-10-16.
What interventions are being tested in trial NCT05618912?
The interventions under investigation include: Hydrocolloid dressing (DEVICE), Petrolatum jelly dressing (OTHER).
Who is sponsoring clinical trial NCT05618912?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05618912's enrollment target sits among peer trials
146 704th of 2000 higher than 1,296 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03490929 · 146 participants · Phase 4
CEUS for Blunt Abdominal Trauma in Children
- NCT04755062 · 146 participants · NA
A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans
- NCT04867954 · 146 participants
Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis
- NCT05051618 · 146 participants · NA
Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI